Search

everythinglearnresearchcommunity

for

Search:↓

Tailored combination therapy improves non-scarring alopecia outcomes.

Early and accurate identification of primary scarring alopecias is crucial to prevent permanent hair loss.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Diffuse unpatterned alopecia can affect donor areas, but treatment with finasteride and minoxidil can improve hair density.

Androgenetic alopecia is the most common type of non-scarring hair loss, especially in young males, and early diagnosis and treatment are important.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Reflectance confocal microscopy can help tell apart scarring from non-scarring hair loss.

Polarized microscopy is a quick and free method to correctly identify types of hair loss.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

The botanical shampoo with Morus alba root extract is safe and effective for treating hair loss.

Videodermoscopy is effective for diagnosing different types of non-scarring hair loss.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.

Low iron levels are strongly linked to chronic hair loss in women.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

Mental health issues affect adaptation in alopecia patients more than the cause of hair loss.

The combined Selencin treatment effectively reduces hair loss and improves hair health after COVID-19.